J Korean Acad Child Adolesc Psychiatry.  2007 Apr;18(1):16-25.

The Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder(III): Pharmacologic Treatment

Affiliations
  • 1Department of Psychiatry, Seoul National University Bundang Hospita, Seoul, Korea.
  • 2Department of Psychiatry, Chonnam National University Hospita, Gwangju, Korea.
  • 3Department of Psychiatry, Sungkyunkwan University, School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea. ntour@unitel.co.kr.
  • 4Maum to Maum Clinic, Seoul, Korea.
  • 5Department of Psychiatry Seoul National University Hospital, Seoul, Korea.
  • 6Department of Psychiatry, School of Medicine, Pusan National University, Busan, Korea.
  • 7Department of Psychiatry, Hanyang University Medical School, Seoul, Korea.
  • 8Department of Psychiatry University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 9Department of Psychiatry, Kwandong University College of Medicine, Myong-Ji Hospital, Goyang, Korea.
  • 10Department of psychiatry, Hallym University College of Medicine, Anyang, Korea.

Abstract

The objective of this review is to propose the Korean practice guideline for pharmacological treatment of attentiondeficit hyperactivity disorder(ADHD). For making the guideline, the authors used the evidence-base approaches derived from a detailed review of literature including wide range of controlled clinical trials, studies of side effects of drugs, toxicological reports, and meta-analyses published in United States and Europe, as well as inside Korea. The review committee composed of experts in ADHD in Korea has reviewed the parameter. The practice parameter for pharmacological treatment describes the use of stimulants, atomoxetine, modafinil, bupropion, tricyclic antidepressants, and alpha-adrenergic agonists and their side effects. The recommendations of pharmacological treatment are proposed at the end of the article.

Keyword

ADHD; Pharmacological Treatment; Practice Parameter

MeSH Terms

Adrenergic alpha-Agonists
Advisory Committees
Antidepressive Agents, Tricyclic
Bupropion
Europe
Korea
United States
Atomoxetine Hydrochloride
Adrenergic alpha-Agonists
Antidepressive Agents, Tricyclic
Bupropion
Full Text Links
  • JKACAP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr